AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Vildip-M50 Tablet

Prescription Icon
Prescription Required

Marketer

Medicaid Labs LLP

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildip-M50 Tablet

Metformin-Glibenclamide 50mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the probability of cardiovascular events. Prescribed independently or in conjunction with other antidiabetic agents, optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; discontinuation should only occur under medical guidance. Effective blood sugar regulation prevents future complications. Maintaining the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect when combined with insulin or sulfonylureas, requires awareness and appropriate management strategies. This medication isn't universally suitable. Prior to commencement, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Potential drug interactions necessitate complete disclosure of all medications to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Kidney function and blood glucose levels are monitored regularly throughout treatment.

Primary Ingredients of Vildip-M50 Tablet

There is no text provided to rephrase.

Uses of Vildip-M50 Tablet

Managing type 2 diabetes

Major Benefits of Vildip-M50 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildip-M50 Tablets should be administered with a meal.

Common Side effects of Vildip-M50 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildip-M50 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildip-M50 Tablets should be taken with a meal.

How Vildip-M50 Tablet works:

Metformin and vildagliptin, combined as Vildip-M50, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Vildip-M50 Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vildip-M50 Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Vildip-M50 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildip-M50 Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver disease should not take Vildip-M50 Tablets; use is strongly discouraged. Seek medical advice before use.

What if you forget to take Vildip-M50 Tablet :

Should you forget a Vildip-M50 Tablet dose, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildip-M50 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildip-M50 Tablet

Vildip-M50 Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vildip-M50 Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vildip-M50 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildip-M50 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Vildip-M50 Tablet use may cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Vildip-M50 Tablet if these symptoms occur.
Prolonged use of Vildip-M50 Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildip-M50 Tablet is safe when used as directed by your doctor. However, even with correct dosage, common side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially with insulin or sulfonylurea) may occur. Report any persistent issues to your doctor.
Vildip-M50 Tablet
149
MRP 172
13% off